Importance of shared decision making in the management of endometrial cancer

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland Pathologist: Dr Tjalling Bosse, Leiden, Netherlands This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME. For further information visit our website:  https://touchoncology.com/education/mdt-for-ici-in-ec/